Lähetä tietue sähköpostilla: Total Tumor Volume on ¹⁸F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with ²²⁵Ac-PSMA-I&T